Core Viewpoint - The company Huada Jiutian (301269) announced the termination of its major asset restructuring plan to acquire 100% of Chip and Semiconductor Technology (Shanghai) Co., Ltd. due to a lack of consensus on key terms among the parties involved, ensuring the protection of the company's and shareholders' interests [1][3]. Group 1 - The decision to terminate the major asset restructuring was made after thorough communication and analysis with relevant parties, and it will not adversely affect the company's current operations or strategic development [3]. - The company plans to hold an investor briefing on July 11, 2025, to discuss the termination of the transaction and engage with investors [3]. - Huada Jiutian, established in 2009 and listed on the ChiNext board in July 2022, focuses on the development and sales of EDA tools and aims to become a leading global EDA provider [3]. Group 2 - Chip and Semiconductor, founded in 2019 with a registered capital of 100 million yuan, specializes in EDA software, integrated passive devices (IPD), and system-level packaging [4]. - The major asset restructuring trend of companies terminating such transactions is noted, with another company, China Nuclear Technology, also announcing a similar termination due to changes in market conditions and the target company's situation [5].

Group 1 - Sannuo Group expects a net loss of 100 million to 120 million yuan for the first half of 2025, a significant decline from a profit of 7.4 million yuan in the same period last year [1] - The company anticipates a net loss of 77 million to 95 million yuan after excluding non-recurring gains and losses [1] - Basic earnings per share are projected to be a loss of 0.2148 to 0.2578 yuan per share [1] Group 2 - Landai Technology is planning to transfer 18% of its shares, which may lead to a change in control [2] - The stock of Landai Technology has been suspended from trading since July 8, 2025, with an expected suspension period of no more than two trading days [2] Group 3 - Xinxin Co. announced that a senior executive plans to reduce their holdings by up to 750,000 shares, representing no more than 0.2971% of the total share capital [3] - The reason for the reduction is personal financial needs [3] Group 4 - Biyimi plans to reduce its shares by a total of up to 3% by two shareholders, with one shareholder planning to reduce up to 139.68 million shares (2.00%) and the other up to 69.84 million shares (1.00%) [4] - The reason for the reduction is also personal financial needs [4] Group 5 - Changxin Bochuang announced that shareholders plan to reduce their holdings by up to 2.95%, totaling 8.6 million shares [6] - The reason for the reduction is personal financial needs [6] Group 6 - Tianci Materials plans to publicly issue H-shares and apply for listing on the Hong Kong Stock Exchange [9] Group 7 - Sanxiang Impression announced the termination of a previous equity transfer agreement, following a request from its controlling shareholder [10] Group 8 - Zhongke Technology has decided to terminate its plan to issue shares for asset acquisition and related fundraising due to changes in market conditions [12] Group 9 - Hangcha Group's subsidiary plans to acquire 99.23% of Guozu Robot's shares through capital increase [14] Group 10 - Xishan Technology plans to increase its holdings in the company by no less than 5 million and no more than 10 million yuan [19] Group 11 - New Hope reported sales of 1.33 million pigs in June, a year-on-year increase of 3.38% [21] - The sales revenue was 1.871 billion yuan, a year-on-year decrease of 19.14% [21] Group 12 - Auhua Endoscope announced that two shareholders plan to reduce their holdings by up to 1.92% [18] Group 13 - Star Source Material has submitted an application for H-share issuance and listing [18] Group 14 - Yilian Technology plans to invest 20 million yuan to establish a partnership with professional institutions [30]

Core Viewpoint - The merger and acquisition plan of China Nuclear Technology has been terminated due to changes in market conditions and the actual situation of the target company, which were different from the initial planning stage [2][3]. Group 1: Transaction Details - China Nuclear Technology announced the termination of the share issuance for asset acquisition and related fundraising on July 7 [2]. - The original plan involved acquiring 100% of the shares of China Nuclear Western Instrumentation from various stakeholders, including China Nuclear Engineering and Guohua Development [2]. - The transaction was expected to constitute a significant asset restructuring, enhancing the integration of resources within the nuclear equipment manufacturing sector [3]. Group 2: Financial Performance of Target Company - China Nuclear Western Instrumentation reported revenues of 1.149 billion, 1.324 billion, and 663 million for the years 2022, 2023, and the first nine months of 2024, respectively [3]. - The net profits for the same periods were 177 million, 164 million, and approximately 81.6 million [3]. Group 3: Company Communication and Future Plans - China Nuclear Technology stated that the decision to terminate the transaction was made after careful consideration and communication with the counterparties, ensuring no adverse impact on the company's operations or financial status [3]. - An investor briefing will be held on July 10 to discuss the termination of the transaction and engage with investors [4].

Group 1 - The company has decided to terminate the plan for issuing shares to purchase assets and raise supporting funds due to changes in the market environment and the actual situation of Xi'an Zhongke Nuclear Instrument Co., Ltd. since the initial planning of the transaction [1][2] - The decision was made unanimously by the supervisory board, with all three attending members voting in favor of the resolution [1] - The supervisory board emphasized that the termination of the transaction is aimed at protecting the long-term interests of the company and its investors [1]

Core Viewpoint - China Nuclear Technology announced the termination of the transaction to acquire 98.87% of Xi'an China Nuclear Instrument Co., Ltd. due to changes in market conditions and the actual situation of the target company [1][6][10] Group 1: Transaction Details - The planned transaction was expected to constitute a major asset restructuring and related party transaction, aligning with the industry's trend of enhancing competitiveness through mergers and acquisitions [1][6] - The transaction was part of China Nuclear Group's strategy to inject quality assets into its listed companies, with both China Nuclear Technology and Xi'an China Nuclear Instrument being controlled by China Nuclear Group [1][5] - The transaction involved multiple parties, including China Nuclear Power Engineering Co., Ltd. and various investment funds, all under the control of China Nuclear Group [3][5] Group 2: Financial Data - As of September 30, 2024, China Nuclear Technology reported total assets of 2.663 billion yuan and net assets of 1.491 billion yuan [2] - The company's revenue for 2022, 2023, and the first three quarters of 2024 were 1.149 billion yuan, 1.324 billion yuan, and 663 million yuan, respectively, with net profits of 177 million yuan, 164 million yuan, and 81.6 million yuan [1][2] - The total liabilities as of September 30, 2024, were 1.172 billion yuan, with total equity of 1.491 billion yuan [2] Group 3: Strategic Implications - The termination of the transaction is seen as a setback for China Nuclear Technology, which aimed to enhance its strength and core competitiveness in the nuclear equipment manufacturing sector [6][7] - Xi'an China Nuclear Instrument is recognized as a key supplier in the nuclear industry, specializing in radiation monitoring systems and other safety systems, indicating its strong market position [6] - The company had anticipated that the transaction would improve its profitability and investment value, aligning with industry development trends [7]

Core Viewpoint - Several listed companies in the Shanghai and Shenzhen markets have announced significant developments, including management changes, stock trading fluctuations, and major contracts, which may present investment opportunities and risks for investors [2]. Group 1: Management Changes and Legal Issues - Scanda's chairman and general manager, Li Yuejie, along with director Zhu Chuncheng, have been subjected to criminal coercive measures due to alleged violations related to information disclosure [3]. - Longhong High-Tech is planning to acquire 100% equity of Guangxi Changke, leading to a stock suspension for up to 10 trading days [6]. Group 2: Stock Trading and Performance - New Asia Electronics reported abnormal stock trading with a cumulative price deviation exceeding 20% over three days, while confirming that its operations are normal and consistent with previously disclosed share reduction plans [5]. - ST Tiexin announced the removal of risk warnings and a name change, which will increase the trading limit from 5% to 10% [8]. Group 3: Financial Performance Forecasts - Industrial Fulian expects a net profit increase of 36.84% to 39.12% year-on-year for the first half of 2025, driven by a surge in AI-related business [18]. - Huayou Cobalt anticipates a net profit increase of 55.62% to 67.59% for the same period, benefiting from integrated operations and rising cobalt prices [19]. - Guoli Co. forecasts a staggering net profit increase of 130.91% to 158.08% for the first half of 2025, attributed to new product and market expansions [20]. - Bangji Technology expects a net profit increase of 166.77% to 200.91%, driven by increased sales from direct sales channels [21]. - Lier Chemical predicts a net profit increase of 185.24% to 196% due to rising product sales and cost reduction efforts [25]. Group 4: Major Contracts and Projects - Huadian Science and Technology signed significant contracts worth approximately RMB 25.16 billion for coal handling and transportation systems [41]. - Aerospace Engineering is the first candidate for a project with a bid of RMB 23.92 billion for a coal gasification facility [43].

Core Viewpoint - China Nuclear Technology has decided to terminate the major asset restructuring plan due to changes in market conditions and the actual situation of the target company, Xi'an China Nuclear Instrument Co., Ltd. [2][7] Group 1: Company Overview - China Nuclear Technology announced the termination of the transaction to acquire 98.87% of Xi'an China Nuclear Instrument Co., Ltd. and raise matching funds, which was expected to constitute a major asset restructuring and related party transaction [5][7]. - The transaction was part of a strategy by China National Nuclear Corporation (CNNC) to inject quality assets into its listed companies, enhancing competitiveness through mergers and acquisitions [5][6]. Group 2: Financial Data - As of September 30, 2024, China Nuclear Technology reported total assets of 2.663 billion yuan and net assets of 1.491 billion yuan [7]. - The operating revenues for 2022, 2023, and the first three quarters of 2024 were 1.149 billion yuan, 1.324 billion yuan, and 663 million yuan, respectively, with net profits of 177 million yuan, 164 million yuan, and 81.6 million yuan [7][16]. Group 3: Market Environment - The decision to terminate the transaction was influenced by changes in the market environment and the actual conditions of Xi'an China Nuclear Instrument Co., Ltd. since the initial planning of the transaction [7][14]. - The restructuring was seen as a way to strengthen the competitive position of companies in the nuclear industry, which is experiencing a trend towards consolidation among leading firms [18]. Group 4: Strategic Implications - The termination of the transaction means that the expected benefits, such as enhancing core competitiveness in the nuclear equipment manufacturing sector, will not be realized [15][16]. - The planned fundraising was intended to cover transaction-related taxes and fees, support project construction, and improve liquidity for both China Nuclear Technology and Xi'an China Nuclear Instrument Co., Ltd. [13][14]. Group 5: Stock Performance - As of July 7, the stock price of China Nuclear Technology was 21.72 yuan per share, with a total market capitalization of 8.328 billion yuan [19].

综上，本次董事会审议事项符合法律、法规和政策的相关规定以及公司的利益，对公司 及全体股东公平、合理，不存在损害公司及其股东利益的情形，我们同意公司终止本次交易 事项，并同意将相关议案提交公司董事会审议。 本页无正文，为《中核苏阀科技实业股份有限公司独立董事专门会议关于终止发行股份购买 资产并募集配套资金暨关联交易事项的审核意见》之签字页 独立董事签字： 中核苏阀科技实业股份有限公司独立董事专门会议 关于终止发行股份购买资产并募集配套资金暨关联交易事 项的审核意见 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司独立董 事管理办 法》等法律、法规、规范性文件以及《公司章程》等有关规定，中核苏阀科技实业股份有限 公司（以下简称"公司"）独立董事已在公司第八届董事会第十八次会议召开之前，召开独 立董事专门会议，认真审查董事会提供的会议资料，审议通过与本次交易相关的议案。 在审阅有关资料和听取相关汇报后，公司独立董事对公司董事会审议的关于 公司拟通 过发行股份的方式购买西安中核核仪器股份有限公司（以下简称"中核西仪"）股份并募集 配套资金暨关联交易事项（以下简称"本次交易"）的相关议案，发表审核意见如下 ...

股票代码: 000777 公司简称：中核科技 公告编号:2025-046 中核苏阀科技实业股份有限公司关于终止发行股份 购买资产并募集配套资金暨关联交易事项的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 中核苏阀科技实业股份有限公司（以下简称"公司"）于 2025 年 7 月 7 日召开第八届 董事会第十八次会议、第八届监事会第十五次会议，审议通过了《关于终止发行股份购买资 产并募集配套资金暨关联交易事项的议案》，同意公司终止发行股份购买资产并募集配套资 金暨关联交易（以下简称"本次交易"）事项，公司独立董事专门会议审议通过相关议案， 并发表了同意终止本次交易的审核意见。 现将有关事项公告如下： 一、本次交易的基本情况 公司拟以发行股份方式购买中国核电工程有限公司持有的西安中核核仪器股份有限公 司（以下简称 "标的公司"）71.96%股份、国华军民融合产业发展基金（有限合伙）持有 的标的公司 11.21%股份、融核产业发展基金（海盐）合伙企业（有限合伙）持有的标的公司 8.41%股份、华舆正心（天津）股权投资基金合伙企业（有限合伙）持有的标的公司 5. ...

说明会具体安排如下： 一、说明会召开的时间、地点和方式 （一）召开时间：2025 年 7 月 10 日（星期四） 15:00-16:00。 （二）召开方式：网络文字互动方式。 股票代码: 000777 公司简称：中核科技 公告编号:2025-048 关于召开终止发行股份购买资产并募集配套资金 暨关联交易事项投资者说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 中核苏阀科技实业股份有限公司（以下简称"公司"）于 2025 年 7 月 7 日召开第八届 董事会第十八次会议、第八届监事会第十五次会议，审议通过了《关于终止发行股份购买资 产并募集配套资金暨关联交易事项的议案》，同意公司终止发行股份购买资产并募集配套资 金暨关联交易（以下简称"本次交易"）事项，公司独立董事专门会议审议通过相关议案， 并发表了同意终止本次交易的审核意见。具体内容详见公司于 2025 年 7 月 8 日披露的《中 核苏阀科技实业股份有限公司关于终止发行股份购买资产并募集配套资金暨关联交易事项 的公告》（公告编号：2025-046）。 为加强与投资者的沟通和交流，公司将于 20 ...